Fennec announces new PEDMARK research to be presented at 2026 ASCO Annual Meeting

Filed May 22, 2026 · Period ending May 21, 2026 · ~1 min read

Key Changes

• medium

  New research on PEDMARK will be presented at the American Society of Clinical Oncology Annual Meeting, evaluating the drug across multiple patient populations and tumor types beyond its current approved use.

  Item 7.01 verify on EDGAR →
• low

  Filing is a routine Regulation FD disclosure under Item 7.01, with information not deemed 'filed' under securities laws or incorporated by reference into other filings.

  Item 7.01 verify on EDGAR →